Addressing Skyrocketing Cancer Drug Prices Comes With Tradeoffs
Authors:
- 1 April 2016
- journal article
- viewpoint
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 2 (4) , 425-426
Abstract
This Viewpoint asserts that the current model for cancer drug pricing in the United States is not sustainable, harms patients and families and the health care sKeywords
This publication has 1 reference indexed in Scilit:
- In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer DrugsMayo Clinic Proceedings, 2015